VIA Pharmaceuticals (VIA Pharmaceuticals) Cash-to-Debt : 0.01 (As of Dec. 2010)

VIA Pharmaceuticals Cash-to-Debt Chart

VIA Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
Cash-to-Debt		Get a 7-Day Free Trial					0.42	11,549.50	No Debt	0.22	0.01

VIA Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
Cash-to-Debt	Get a 7-Day Free Trial															0.22	0.05	0.01	0.02	0.01

Competitive Comparison of VIA Pharmaceuticals's Cash-to-Debt

For the Biotechnology subindustry, VIA Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIA Pharmaceuticals's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIA Pharmaceuticals's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where VIA Pharmaceuticals's Cash-to-Debt falls into.

VIA Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

VIA Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Dec. 2010 is calculated as:

VIA Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Dec. 2010 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VIA Pharmaceuticals  (GREY:VIAP) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

VIA Pharmaceuticals Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of VIA Pharmaceuticals's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

VIA Pharmaceuticals (VIA Pharmaceuticals) Business Description